PubMed · 2017 · 28 citations · 39 references
MedicineOncologyPharmacologyCancer PharmacologyDna RepairMolecular OncologyCancer Cell SignalingColorectal CancerMalignant NeoplasmsPharmacodynamics Of Anticancer AgentsSignal Transduction In CancerCancer Cell RadiosensitivityIntrinsic RadiosensitivityNonsteroidal Anti-inflammatory Drug PharmacologyP53-mediated Radiation ResponseTherapeutic RadiosensitizationTumor RadiosensitivityTumor Suppression MechanismsTumor Suppression Pathways
It has been reported that celecoxib, a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug (NSAID), regulates the radiosensitivity of several cancer cells. BCCIP (BRCA2 and CDKN1A interacting protein) plays a critical role in maintaining the critical functions of p53 in tumor suppression and response to therapy. However, whether the effect of celecoxib on the radiosensitivity of colorectal cancer (CRC) cells is dependent on BCCIP is largely unclear. In this study, we found that celecoxib enhanced the radiosensitivity of HeLa (a human cervical carcinoma cell line), A549 (a human lung carcinoma cell line), and HCT116 cells (a human CRC cells line). Among these cells, COX-2 expression was undetected in HCT116 cells. Treatment with celecoxib significantly increased BCCIP expression in COX-2 negative HCT116 cells. Knockdown of BCCIP obviously abrogated the enhanced radiosensitivity of HCT116 cells induced by celecoxib. A combination of celecoxib and irradiation treatment induced much more γ-H2AX foci formation, higher levels of radiation injury-related proteins phosphorylation, G2/M arrest, apoptosis, and p53 and p21 expression, and lower levels of Cyclin B1 in HCT116 cells than those in cells treated with irradiation alone. However, these changes were undetected in BCCIP-silenced HCT116 cells. Therefore, these data suggest that BCCIP gene may be a radiosensitivity-related gene in CRC. Celecoxib affects the functions of p53 and inhibits the recovery from the irradiation-induced injury by up-regulating the expression of BCCIP, and subsequently regulates the expressions of genes such as p21 and Cyclin B1 to enhance the radiosensitivity of HCT116 cells in a COX-2 independent manner.
39
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Peter Y. Park, Teresa A. Goldin, John C. S. Chang et al. · Case Reports in Oncology · 2015 · 5.3K citations · Full text
Clonogenic assay of cells in vitro
Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Jean-François Bosset, Laurence Collette, G. Calais et al. · New England Journal of Medicine · 2006 · 2.7K citations · Full text